EcoDrugPlus

Ensembl ID : ENSDLAG00005026305
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSDLAG00005026407
Gene Symbol: -
Cross references: -
224 Possible Orthologues:

Ensembl ID : ENSDLAG00005026454
Gene Symbol: -
Cross references: -
378 Possible Orthologues:

Ensembl ID : ENSDLAG00005026507
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSDLAG00005026539
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSDLAG00005026609
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSDLAG00005026225
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSDLAG00005026559
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSDLAG00005026576
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSDLAG00005026766
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSDLAG00005027225
Gene Symbol: -
Cross references: -
351 Possible Orthologues:

Ensembl ID : ENSDLAG00005027226
Gene Symbol: -
Cross references: -
351 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).